Neurotrophins are key signaling molecules in the development and maintenance of the nervous system. This proposal describes research investigating the function of neurotrophin-3 (NT-3) in the mouse hippocampus and control of NT-3 expression following injury. Studies of expression will utilize a transgenic mouse having the lac Z gene targeted to the NT-3 locus, enabling the location and quantity of NT-3 expression to be easily determined through the use of specific beta- galactosidase substrates. Studies will be performed both in vivo and in vitro to determine the effects of seizure-inducing drugs such as quinolinic and kainic acids on NT-3 levels in distinct parts of the hippocampus and uncover any modulation of these NT-3 responses by specific cytokines and growth factors. Combined X-gal histochemistry and immunocytochemistry will be used to determine the cellular localization of altered NT-3 levels following seizure induction. The majority of transgenic mice lacking NT-3 die shortly after birth, making it impossible to identify the ultimate consequences of an absence of NT-3 in the CNS. Creation of a conditional NT-3 mutant using the cre- lox system is proposed. The goal of this project is to create mice lacking NT-3 only in the forebrain. These mice are expected to be viable and will be studied for alterations in CNS morphology and behavioral abnormalities. The potent neuronal survival-promoting effect of neurotrophins leads to the testable prediction that these mutant mice will be abnormally susceptible to seizure-induced neurodegeneration. Elucidation of the functions and regulation of NT-3 in the hippocampus promises to have important clinical and therapeutic implications for human conditions in which hippocampal neurons degenerate, such as epilepsy, stroke, CNS injury and Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01NS001872-03
Application #
2771870
Study Section
NST-2 Subcommittee (NST)
Program Officer
Jacobs, Margaret
Project Start
1996-09-27
Project End
2000-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Colorado at Boulder
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
City
Boulder
State
CO
Country
United States
Zip Code
80309
Vigers, A J; Amin, D S; Talley-Farnham, T et al. (2012) Sustained expression of brain-derived neurotrophic factor is required for maintenance of dendritic spines and normal behavior. Neuroscience 212:1-18
Vigers, Alison J; Bottger, Barbel; Baquet, Zachary C et al. (2003) Neurotrophin-3 is expressed in a discrete subset of olfactory receptor neurons in the mouse. J Comp Neurol 463:221-35
Farinas, I; Jones, K R; Tessarollo, L et al. (2001) Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J Neurosci 21:6170-80
Vigers, A J; Baquet, Z C; Jones, K R (2000) Expression of neurotrophin-3 in the mouse forebrain: insights from a targeted LacZ reporter. J Comp Neurol 416:398-415